| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |